List of Tables
    Table 1. Monoclonal Antibody Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Monoclonal Antibody Treatment Market Trends
    Table 3. Monoclonal Antibody Treatment Market Drivers
    Table 4. Monoclonal Antibody Treatment Market Challenges
    Table 5. Monoclonal Antibody Treatment Market Restraints
    Table 6. Global Monoclonal Antibody Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Monoclonal Antibody Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Monoclonal Antibody Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Monoclonal Antibody Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Monoclonal Antibody Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Monoclonal Antibody Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Monoclonal Antibody Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Monoclonal Antibody Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Monoclonal Antibody Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2021)
    Table 15. Top Players of Monoclonal Antibody Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Monoclonal Antibody Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Monoclonal Antibody Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Monoclonal Antibody Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Monoclonal Antibody Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Monoclonal Antibody Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Monoclonal Antibody Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Monoclonal Antibody Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Monoclonal Antibody Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Monoclonal Antibody Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Monoclonal Antibody Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Monoclonal Antibody Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Monoclonal Antibody Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Monoclonal Antibody Treatment Product
    Table 33. Pfizer Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Bayer Company Details
    Table 36. Bayer Business Overview
    Table 37. Bayer Monoclonal Antibody Treatment Product
    Table 38. Bayer Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 39. Bayer Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Monoclonal Antibody Treatment Product
    Table 43. Sanofi Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck Monoclonal Antibody Treatment Product
    Table 48. Merck Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. GlaxoSmithKline Company Details
    Table 51. GlaxoSmithKline Business Overview
    Table 52. GlaxoSmithKline Monoclonal Antibody Treatment Product
    Table 53. GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline Recent Development
    Table 55. Roche Company Details
    Table 56. Roche Business Overview
    Table 57. Roche Monoclonal Antibody Treatment Product
    Table 58. Roche Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 59. Roche Recent Development
    Table 60. Novartis Company Details
    Table 61. Novartis Business Overview
    Table 62. Novartis Monoclonal Antibody Treatment Product
    Table 63. Novartis Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 64. Novartis Recent Development
    Table 65. AbbVie Company Details
    Table 66. AbbVie Business Overview
    Table 67. AbbVie Monoclonal Antibody Treatment Product
    Table 68. AbbVie Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 69. AbbVie Recent Development
    Table 70. Shanghai Junshi Biosciences Co.,Ltd Company Details
    Table 71. Shanghai Junshi Biosciences Co.,Ltd Business Overview
    Table 72. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product
    Table 73. Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 74. Shanghai Junshi Biosciences Co.,Ltd Recent Development
    Table 75. Innovent Biologics Company Details
    Table 76. Innovent Biologics Business Overview
    Table 77. Innovent Biologics Monoclonal Antibody Treatment Product
    Table 78. Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 79. Innovent Biologics Recent Development
    Table 80. Jiangsu Hengrui Medicine Co.,Ltd. Company Details
    Table 81. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
    Table 82. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product
    Table 83. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 84. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
    Table 85. BeiGene, Ltd. Company Details
    Table 86. BeiGene, Ltd. Business Overview
    Table 87. BeiGene, Ltd. Monoclonal Antibody Treatment Product
    Table 88. BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 89. BeiGene, Ltd. Recent Development
    Table 90. Grand Pharmaceutical (China) Co., Ltd Company Details
    Table 91. Grand Pharmaceutical (China) Co., Ltd Business Overview
    Table 92. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product
    Table 93. Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 94. Grand Pharmaceutical (China) Co., Ltd Recent Development
    Table 95. Henlius Company Details
    Table 96. Henlius Business Overview
    Table 97. Henlius Monoclonal Antibody Treatment Product
    Table 98. Henlius Revenue in Monoclonal Antibody Treatment Business (2017-2022) & (US$ Million)
    Table 99. Henlius Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Monoclonal Antibody Treatment Product Picture
    Figure 2. Global Monoclonal Antibody Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Monoclonal Antibody Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Monoclonal Antibody Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Monoclonal Antibody Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Monoclonal Antibody Treatment Market Share in Global 2017-2028
    Figure 7. Monoclonal Antibody Treatment Report Years Considered
    Figure 8. Product Picture of Cancer
    Figure 9. Product Picture of Autoimmune Diseases
    Figure 10. Product Picture of Exogenous Infection
    Figure 11. Product Picture of Hematological Diseases
    Figure 12. Global Monoclonal Antibody Treatment Market Share by Type in 2022 & 2028
    Figure 13. Global Monoclonal Antibody Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Monoclonal Antibody Treatment Market Share by Type (2017-2028)
    Figure 15. United States Monoclonal Antibody Treatment Market Share by Type in 2022 & 2028
    Figure 16. United States Monoclonal Antibody Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Monoclonal Antibody Treatment Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Others
    Figure 21. Global Monoclonal Antibody Treatment Market Share by Application in 2022 & 2028
    Figure 22. Global Monoclonal Antibody Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Monoclonal Antibody Treatment Market Share by Application (2017-2028)
    Figure 24. United States Monoclonal Antibody Treatment Market Share by Application in 2022 & 2028
    Figure 25. United States Monoclonal Antibody Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Monoclonal Antibody Treatment Market Share by Application (2017-2028)
    Figure 27. North America Monoclonal Antibody Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. United States Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Monoclonal Antibody Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Monoclonal Antibody Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. China Taiwan Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Monoclonal Antibody Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Monoclonal Antibody Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Monoclonal Antibody Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 55. Bayer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 57. Merck Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 61. AbbVie Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 62. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 63. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 64. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 65. BeiGene, Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 66. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 67. Henlius Revenue Growth Rate in Monoclonal Antibody Treatment Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed